| 2011 | Nilotinib Combined with Multi-Agent Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Interim Results of Korean Adult ALL Working Party Phase 2 Study | 문영철 | Meeting Abstract |
| 2015 | Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia | 문영철 | Article |
| 2017 | Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia | 허정원; 문영철; 정혜선; 정태동 | Article |
| 2023 | Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170) | 문영철 | Article |
| 2022 | Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909) | 문영철 | Article |
| 2020 | Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia | 문영철 | Article |
| 2007 | Outgrowing endothelial cells that are derived from human umbilical cord blood improve neovascularization in hind-limb ischemia. | 성주명; 유은선; 권기환; 이경은; 문영철 | Meeting Abstract |
| 2020 | Peroxiredoxin 3 has important roles on arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line via hyperoxidation of mitochondrial specific reactive oxygen species | 성주명; 유은선; 허정원; 이경은; 문영철; 남은미; 우현애 | Article |
| 2017 | PEROXIREDOXIN II ACTIVITY HAS IMPORTANT ROLES TO CONTROL ABL TYROSINE KINASE ACTIVITY IN STIS TREATED CML PATIENTS AND ITS POTENTIAL APPLICATION IN IMATINIB RESISTANCE | 문영철 | Meeting Abstract |
| 2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | 문영철 | Article |
| 2017 | Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia | 문영철 | Article |
| 2022 | Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma | 이경은; 문영철 | Article |
| 2011 | Polymorphisms of ERCC1 and ERCC5 genotypes were associated with response to imatinib therapy in chronic phase chronic myeloid leukemia | 공지현 | Doctoral Thesis |
| 2012 | Polymorphisms of ERCC1 genotype associated with response to imatinib therapy in chronic phase chronic myeloid leukemia | 문영철 | Article |
| 2020 | Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study) | 문영철 | Article |
| 2005 | Potential usefulness of leukotriene B4 (LTB4) on mobilization of hematopoietic progenitor cells (HPC) | 성주명; 문영철 | Meeting Abstract |
| 2005 | Predictable prognostic factor of CD56 expression in acute myeloid leukemia with t(8 : 21) including allogeneic hematopoietic stem cell transplantation | 성주명; 문영철 | Meeting Abstract |
| 2007 | Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation | 성주명; 문영철 | Article |
| 2013 | Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib | 문영철 | Article |
| 2015 | PREDICTIVE FACTORS FOR TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH IMATINIB-TREATED, UNDETECTABLE MOLECULAR RESIDUAL DISEASE: RESULTS FROM THE KID STUDY | 문영철 | Meeting Abstract |
| 2015 | Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib | 문영철 | Meeting Abstract |
| 2017 | Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation | 문영철 | Article |
| 2014 | Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines. | 문영철 | Article |
| 2009 | Prognostic Factors and Clinical Outcomes of High-Dose Chemotherapy followed by Autologous Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma, Unspecified: Complete Remission at Transplantation and the Prognostic Index of Peripheral T Cell Lymphoma Are the Major Factors Predictive of Outcome | 문영철 | Article |
| 2012 | Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) | 문영철 | Article |
| 2016 | Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome | 성주명; 문영철 | Article |
| 2006 | Prognostic significance of CD44s expression in bile duct carcinomas | 이순남; 성주명; 조민선; 이경은; 문영철 | Meeting Abstract |
| 2008 | Prognostic significance of CD44s expression in biliary tract cancers | 이순남; 성주명; 조민선; 이현국; 민석기; 이경은; 문영철; 남은미 | Conference Paper |
| 2023 | Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high-risk essential thrombocythemia | 문영철; 박동진; 박영훈; 이세원 | Article |
| 2002 | Prospective CD34+ cell mobilization trial comparing SQ vs IV G-CSF on normal individuals. | 이순남; 이미애; 정화순; 성주명; 임석아; 유은선; 이경은; 문영철 | Meeting Abstract |
